🇺🇸 FDA

Intelligence Platform

Patents

Browse 9 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12215133

GIP and GLP-1 dual receptor agonist, pharmaceutical composition, and use

BrightGene Bio-Medical Technology Co., Ltd. · Granted Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11191843

Multi-arm targeting anti-cancer conjugate

BrightGene Bio-Medical Technology Co., Ltd. · Granted Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11179467

Exenatide modifier and use thereof

BrightGene Bio-Medical Technology Co., Ltd. · Granted Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10869863

Multi-arm polymeric targeting anti-cancer conjugate

BrightGene Bio-Medical Technology Co., Ltd. · Granted Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10759905

Biodegradable amphiphilic polymer, polymeric vesicles prepared therefrom, and application

BrightGene Bio-Medical Technology Co., Ltd. · Granted Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10689413

Composition enriched in single isomer of NUC-1031 and preparation method and use thereof

BrightGene Bio-Medical Technology Co., Ltd. · Granted Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10292940

Hyaluronic acid-based amphiphilic polymer, preparation method and application thereof

BrightGene Bio-Medical Technology Co., Ltd. · Granted Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9796728

Cyclic carbonate monomer containing double-sulfur five-membered ring functional group, and

BrightGene Bio-Medical Technology Co., Ltd. · Granted Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8507463

Nucleotide analogue prodrug and the preparation thereof

BrightGene Bio-Medical Technology Co., Ltd. · Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted